| Financial Year |
March 31 2023 |
| Monetary Funds |
1,667,991,843.69 |
| Held-for-trading Financial Assets |
342,023,768.49 |
| Notes Receivable |
18,450,000.00 |
| Accounts Receivable |
1,000,104,507.30 |
| Advances to Suppliers |
235,060,069.91 |
| Other Receivables |
13,638,382.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,894,308,474.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
486,139,270.19 |
| Total Current Assets |
6,657,716,316.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
98,783,895.43 |
| Investment Properties |
1,962,081.34 |
| Fixed Assetes |
10,941,364,807.38 |
| Under-construction Projects |
164,739,729.36 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
467,785,278.90 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
297,453,881.52 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,977,719.32 |
| Deferred Income Tax Assets |
38,010,456.74 |
| Other Non-Current Assets |
162,406,872.43 |
| Sub-Total of Non-Current Assets |
12,991,753,751.53 |
| Total Assets |
19,649,470,068.37 |
| Short-Term Loans |
5,703,297,551.90 |
| Trading Financial liabilities |
-- |
| Notes Payable |
899,029,164.41 |
| Accounts Payable |
1,164,646,660.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
191,705,891.85 |
| Taxes Payable |
60,981,766.07 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
241,332,019.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
266,156,118.94 |
| Other Current Liabilities |
3,497,874.55 |
| Sub-Total of Current Liabilities |
8,665,283,909.77 |
| Long-term Loans |
170,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,645,897.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
935,616,751.32 |
| Total Liabilities |
9,600,900,661.09 |
| Paid-In Capital(Or Share Stock) |
1,243,639,674.00 |
| Capital Surplus |
4,241,725,063.40 |
| Surplus Reserve |
846,371,407.76 |
| LESS:Treasury Stock |
93,488,955.42 |
| Undistributed Profits |
3,802,665,957.25 |
| Minority Stockholder's Interest |
7,571,095.46 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,040,998,311.82 |
| Owner's Equity（Stockholder's Equity） |
10,048,569,407.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
19,649,470,068.37 |
